{
  "zip": "78245",
  "sector": "Healthcare",
  "fullTimeEmployees": 2,
  "longBusinessSummary": "OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.",
  "city": "San Antonio",
  "phone": "210-677-6000",
  "state": "TX",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.oncovista.com",
  "maxAge": 1,
  "address1": "14785 Omicron Drive",
  "industry": "Biotechnology",
  "address2": "Suite 104",
  "previousClose": 0.0357,
  "regularMarketOpen": 0.02885,
  "twoHundredDayAverage": 0.028633093,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.035,
  "navPrice": null,
  "averageDailyVolume10Day": 4575,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.0357,
  "fiftyDayAverage": 0.03272727,
  "trailingAnnualDividendRate": null,
  "open": 0.02885,
  "averageVolume10days": 4575,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.47689,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.02825,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 83100,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 420272,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 10920,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.02825,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 83100,
  "fiftyTwoWeekHigh": 0.07,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.01,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.035,
  "exchange": "PNK",
  "shortName": "ONCOVISTA INNOVATIVE THERAPIES ",
  "longName": "OncoVista Innovative Therapies, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "OVIT",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_26079298",
  "uuid": "6262a320-9533-357f-a383-eda241edea74",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -0.362,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 23558500,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.28,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1419984000,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -3270377,
  "trailingEps": -0.147,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1483142400,
  "mostRecentQuarter": 1443571200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": null,
  "enterpriseValue": 1230797,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1193616000,
  "lastSplitFactor": "1:1",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.02885,
  "logo_url": "https://logo.clearbit.com/oncovista.com"
}